Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Cardiac disorder
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': DEPFIZER INC2021571448
Write-up: cardiac disorder; This is a spontaneous report based on information received by Pfizer from Biontech [manufacturer control number: 55711], license party for COMIRNATY. This is a spontaneous report from a contactable other healthcare professional (HCP). A male patient of an unspecified age received first dose of BNT162B2 (COMIRNATY) via unspecified route single dose for COVID-19 immunisation on unspecified date. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient experienced cardiac disorder on an unspecified date. The patient died on an unspecified date. It was reported the patient died after 1. dose (not vaccine related, he had cardiac problems). It was unknown if an autopsy was performed. Outcome of the event was fatal. Lot/batch number has been requested.; Sender''s Comments: Based on the current available information, the event cardiac disorder is most likely related to an intercurrent or underlying condition which is not related to the suspected drug. The case will be reassessed if additional information becomes available.; Reported Cause(s) of Death: cardiac disorder
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166